Azasordarins: Susceptibility of Fluconazole-Susceptible and Fluconazole-Resistant Clinical Isolates of Candida spp. to GW 471558
Open Access
- 1 June 2001
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 45 (6) , 1905-1907
- https://doi.org/10.1128/aac.45.6.1905-1907.2001
Abstract
The in vitro activity of the azasordarin GW 471558 was compared with those of amphotericin B, flucytosine, itraconazole, and ketoconazole against 177 clinical isolates of Candida spp. GW 471558 showed potent activity against Candida albicans , Candida glabrata , and Candida tropicalis , even against isolates with decreased susceptibility to azoles. Candida krusei, Candida parapsilosis, Candida lusitaniae, and Candida guilliermondii are resistant to GW 471558 in vitro (MICs, >128 μg/ml).Keywords
This publication has 5 references indexed in Scilit:
- Pharmacokinetics-Pharmacodynamics of a Sordarin Derivative (GM 237354) in a Murine Model of Lethal CandidiasisAntimicrobial Agents and Chemotherapy, 2000
- Activities of Sordarins in Murine HistoplasmosisAntimicrobial Agents and Chemotherapy, 1999
- Sordarins: In Vitro Activities of New Antifungal Derivatives against Pathogenic Yeasts, Pneumocystis carinii , and Filamentous FungiAntimicrobial Agents and Chemotherapy, 1998
- Sordarins: A New Class of Antifungals with Selective Inhibition of the Protein Synthesis Elongation Cycle in YeastsAntimicrobial Agents and Chemotherapy, 1998
- Identification of Elongation Factor 2 as the Essential Protein Targeted by Sordarins in Candida albicansAntimicrobial Agents and Chemotherapy, 1998